TRADING HALTED

Bausch Health Companies Inc VRX:Swiss Exchange

*Data is delayed | Exchange | CHF
Last | 06/05/19 CET
24.11UNCH (UNCH)
52 week range
21.44 - 24.11
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.11
  • 52 Week High24.11
  • 52 Week High Date06/05/19
  • 52 Week Low21.44
  • 52 Week Low Date06/05/19

Key Stats

  • Market Cap3,460.93M
  • Shares Out360.99M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.11
  • 52 Week High24.11
  • 52 Week High Date06/05/19
  • 52 Week Low21.44
  • 52 Week Low Date06/05/19
  • Market Cap3,460.93M
  • Shares Out360.99M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.37
  • P/E (TTM)-17.60
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bausch Health Companies Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...
John Paulson
Independent Chairman of the Board
Thomas Appio
Chief Executive Officer, Director
John Barresi
Interim Chief Financial Officer
Seana-Lyn Carson
Executive Vice President, General Counsel
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada